Literature DB >> 32614630

Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.

Peng Zhao1,2,3,4, Ming Hou5, Yi Liu6, Hui-Xin Liu7, Rui-Bin Huang8, Hong-Xia Yao9, Ting Niu10, Jun Peng5, Ming Jiang11, Yan-Qiu Han12, Jian-Da Hu13, Hu Zhou14, Ze-Ping Zhou15, Lin Qiu16, Lian-Sheng Zhang17, Xin Wang18, Hua-Quan Wang19, Ru Feng20, Lin-Hua Yang21, Liang-Ming Ma22, Shun-Qing Wang23, Pei-Yan Kong24, Wen-Sheng Wang25, Hui-Ping Sun26, Jing Sun27, He-Bing Zhou28, Tie-Nan Zhu29, Li-Ru Wang30, Jing-Yu Zhang31, Qiu-Sha Huang1,2,3,4, Xiao Liu1,2,3,4, Hai-Xia Fu1,2,3,4, Yue-Ying Li32, Qian-Fei Wang32, Qian Jiang1,2,3,4, Hao Jiang1,2,3,4, Jin Lu1,2,3,4, Xiao-Hui Zhang1,2,3,4.   

Abstract

Intracranial hemorrhage (ICH) is a devastating complication of immune thrombocytopenia (ITP). However, information on ICH in ITP patients under the age of 60 years is limited, and no predictive tools are available in clinical practice. A total of 93 adult patients with ITP who developed ICH before 60 years of age were retrospectively identified from 2005 to 2019 by 27 centers in China. For each case, 2 controls matched by the time of ITP diagnosis and the duration of ITP were provided by the same center. Multivariate analysis identified head trauma (OR = 3.216, 95%CI 1.296-7.979, P =.012), a platelet count ≤ 15,000/μL at the time of ITP diagnosis (OR = 1.679, 95%CI 1.044-2.698, P =.032) and severe/life-threatening bleeding (severe bleeding vs. mild bleeding, OR = 1.910, 95%CI 1.088-3.353, P =.024; life-threatening bleeding vs. mild bleeding, OR = 2.620, 95%CI 1.360-5.051, P =.004) as independent risk factors for ICH. Intraparenchymal hemorrhage (OR = 5.191, 95%CI 1.717-15.692, P =.004) and a history of severe bleeding (OR = 4.322, 95%CI 1.532-12.198, P =.006) were associated with the 30-day outcome of ICH. These findings may facilitate ICH risk stratification and outcome prediction in patients with ITP.

Entities:  

Keywords:  Immune thrombocytopenia; intracranial hemorrhage; outcome; risk stratification

Year:  2020        PMID: 32614630     DOI: 10.1080/09537104.2020.1786042

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  3 in total

1.  Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation.

Authors:  Xiying Ren; Qiusha Huang; Qingyuan Qu; Xuan Cai; Haixia Fu; Xiaodong Mo; Yu Wang; Yawei Zheng; Erlie Jiang; Yishan Ye; Yi Luo; Shaozhen Chen; Ting Yang; Yuanyuan Zhang; Wei Han; Feifei Tang; Wenjian Mo; Shunqing Wang; Fei Li; Daihong Liu; Xiaoying Zhang; Yicheng Zhang; Shuqing Feng; Feng Gao; Hailong Yuan; Dao Wang; Dingming Wan; Huan Chen; Yao Chen; Jingzhi Wang; Yuhong Chen; Ying Wang; Kailin Xu; Tao Lang; Xiaomin Wang; Hongbin Meng; Limin Li; Zhiguo Wang; Yanling Fan; Yingjun Chang; Lanping Xu; Xiaojun Huang; Xiaohui Zhang
Journal:  Blood Adv       Date:  2021-12-14

2.  Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.

Authors:  Shan Chong; Peng Zhao; Rui-Bin Huang; Hu Zhou; Jia-Ning Zhang; Ming Hou; Yi Liu; Hong-Xia Yao; Ting Niu; Jun Peng; Ming Jiang; Yan-Qiu Han; Jian-Da Hu; Ze-Ping Zhou; Lin Qiu; Lian-Sheng Zhang; Xin Wang; Hua-Quan Wang; Ru Feng; Lin-Hua Yang; Liang-Ming Ma; Shun-Qing Wang; Pei-Yan Kong; Wen-Sheng Wang; Hui-Ping Sun; Jing Sun; He-Bing Zhou; Tie-Nan Zhu; Li-Ru Wang; Jing-Yu Zhang; Qiu-Sha Huang; Hai-Xia Fu; Ye-Jun Wu; Yue-Ying Li; Qian-Fei Wang; Qian Jiang; Hao Jiang; Jin Lu; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Blood Adv       Date:  2022-07-26

3.  Immune thrombocytopenia in a patient with COVID-19.

Authors:  Emilie Deruelle; Omar Ben Hadj Salem; Sonnthida Sep Hieng; Claire Pichereau; Hervé Outin; Matthieu Jamme
Journal:  Int J Hematol       Date:  2020-07-16       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.